JP2019531254A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019531254A5 JP2019531254A5 JP2018565319A JP2018565319A JP2019531254A5 JP 2019531254 A5 JP2019531254 A5 JP 2019531254A5 JP 2018565319 A JP2018565319 A JP 2018565319A JP 2018565319 A JP2018565319 A JP 2018565319A JP 2019531254 A5 JP2019531254 A5 JP 2019531254A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- binding fragment
- pharmaceutical composition
- humanized
- humanized antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022033194A JP7408707B2 (ja) | 2016-06-14 | 2022-03-04 | Ｐｒｌ３抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201604834P | 2016-06-14 | ||
| SG10201604834P | 2016-06-14 | ||
| PCT/SG2017/050300 WO2017217934A1 (en) | 2016-06-14 | 2017-06-14 | Prl3 antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022033194A Division JP7408707B2 (ja) | 2016-06-14 | 2022-03-04 | Ｐｒｌ３抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019531254A JP2019531254A (ja) | 2019-10-31 |
| JP2019531254A5 true JP2019531254A5 (enExample) | 2020-06-18 |
Family
ID=60663634
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018565319A Pending JP2019531254A (ja) | 2016-06-14 | 2017-06-14 | Ｐｒｌ３抗体 |
| JP2022033194A Active JP7408707B2 (ja) | 2016-06-14 | 2022-03-04 | Ｐｒｌ３抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022033194A Active JP7408707B2 (ja) | 2016-06-14 | 2022-03-04 | Ｐｒｌ３抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11155636B2 (enExample) |
| EP (1) | EP3469003A4 (enExample) |
| JP (2) | JP2019531254A (enExample) |
| KR (1) | KR102451588B1 (enExample) |
| CN (1) | CN109476759B (enExample) |
| AU (1) | AU2017285995B2 (enExample) |
| BR (1) | BR112018075901A2 (enExample) |
| CA (1) | CA3025756A1 (enExample) |
| SG (1) | SG11201811068YA (enExample) |
| WO (1) | WO2017217934A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119110747A (zh) | 2022-05-11 | 2024-12-10 | 国立研究开发法人产业技术综合研究所 | 氨分离膜及使用了其的氨分离方法 |
| TW202532435A (zh) * | 2023-11-30 | 2025-08-16 | 新加坡科技研究局 | 治療新生血管性眼疾之方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050287644A1 (en) * | 2004-05-14 | 2005-12-29 | Genesis Biotech Inc. | Methods for producing and culturing rabbit-mouse hybridomas and monoclonal antibodies secreted by rabbit-mouse hybridomas |
| US7462697B2 (en) * | 2004-11-08 | 2008-12-09 | Epitomics, Inc. | Methods for antibody engineering |
| EP1848742A1 (en) * | 2005-01-28 | 2007-10-31 | Attogen, Inc. | Anti-prl-3 antibodies and methods of use thereof |
| DK3360571T3 (da) * | 2007-05-03 | 2021-01-04 | Agency For Science Tech And Research Astarstar | Antistoffer, der binder til et intracellulært PRL-1- eller PRL-3-polypeptid |
| WO2010045340A1 (en) * | 2008-10-14 | 2010-04-22 | Centocor Ortho Biotech Inc. | Methods of humanizing and affinity-maturing antibodies |
| SG181113A1 (en) * | 2009-11-30 | 2012-07-30 | Agency Science Tech & Res | Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination |
| JP6343017B2 (ja) * | 2014-02-07 | 2018-06-13 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | 癌の予後診断のためのバイオマーカーおよび療法のためのターゲットとしてのｐｒｌ−３ |
-
2017
- 2017-06-14 CA CA3025756A patent/CA3025756A1/en active Pending
- 2017-06-14 EP EP17813707.1A patent/EP3469003A4/en active Pending
- 2017-06-14 SG SG11201811068YA patent/SG11201811068YA/en unknown
- 2017-06-14 CN CN201780037479.8A patent/CN109476759B/zh active Active
- 2017-06-14 BR BR112018075901-5A patent/BR112018075901A2/pt unknown
- 2017-06-14 US US16/309,439 patent/US11155636B2/en active Active
- 2017-06-14 JP JP2018565319A patent/JP2019531254A/ja active Pending
- 2017-06-14 KR KR1020197001195A patent/KR102451588B1/ko active Active
- 2017-06-14 AU AU2017285995A patent/AU2017285995B2/en active Active
- 2017-06-14 WO PCT/SG2017/050300 patent/WO2017217934A1/en not_active Ceased
-
2022
- 2022-03-04 JP JP2022033194A patent/JP7408707B2/ja active Active